Lakeland Respiratory Consulting Services Inc. has been informed by medical device
manufacturer Philips Respironics that some of its devices equipping patients with respiratory
diseases treated at home may present a potential safety issue with one of the components
(sound abatement foam).
On June 14, 2021, medical device manufacturer Philips Respironics™ issued a Field Safety Notice regarding the recall of respiratory and ventilator devices due to the health risks associated with their use. Full details of the recall are available on the Philips Respironics™ website.
Please see full list of affected models below:
Continuous Ventilator, Minimal Ventilatory Support, Facility use
Continuous Ventilator, Non life supporting – BiPAP
- DreamStation ASV
- DreamStation ST, AVAPS
- SystemOne ASV4
- C-Series ASV
- C-series S/T and AVAPS
- OmniLab Advanced +
- SystemOne (Q-series)
- DreamStation Go
- Dorma 400
- Dorma 500
- REMstar SE Auto
- Trilogy 100
- Trilogy 200
- Garbin Plus, Aeris, LifeVent
Continuous Ventilator, Minimum Ventilatory Support, Facility Use
- A-series BiPAP Hybrid A30
- A-series BiPAP V30 Auto
Continuous Ventilator, Non-life Supporting
- A-series BiPAP A40
- A-series BiPAP A30
The recall does not impact any other devices distributed by Lakeland Respiratory Consulting Services Inc., including the ResMed™ devices.
The recall does not impact the following Philips Respironics™ devices:
- Trilogy Evo
- Trilogy Evo OBM
- Trilogy EV300
- Trilogy 202
- BiPAP A40 EFL
- BiPAP A40 Pro
- DreamStation 2
- Omnilab (original based on Harmony 2)
- Dorma 100, Dorma 200, & REMStar SE
- All oxygen concentrators, respiratory drug delivery products, airway clearance products
We are registering with Philips Respironics™ the serial numbers of all affected devices sold by Lakeland Respiratory Consulting Services Inc., on behalf of our patients and clients, to ensure they are taken into consideration as part of the repair/replacement program under development by Philips Respironics™.
Affected devices will either be replaced with a new or repaired unit that incorporates new material, or be repaired.
Once we receive further information from Philips Respironics™ on its repair/replacement program, we will contact our patients and clients regarding their devices to ensure the appropriate settings of their new or repaired equipment and to assist them throughout this process.
We understand the impact of this situation on our patients’ therapy and it is our priority to support them at all times. However, Philips Respironics™ repair/replacement program may take some time to be put in place as the repair process for existing devices requires regulatory approval in Canada.
Upon this approval, Philips Respironics™ should then be able to initiate its repair/replacement process, and we will work with this manufacturer to deploy it with our patients and minimize inconveniences.
Since we do not yet have instructions from Philips Respironics™, we would request that our patients and clients wait for the repair/replacement program to be launched and instructions from Lakeland Respiratory Consulting Services Inc. before bringing any equipment to our clinics.
We have already initiated the process by registering the serial numbers of our patients and clients’ affected devices serial numbers on Philips Respironics™ dedicated platform. We will update our website and inform our patients and clients once further instructions are communicated by Philips Respironics™.
Most of the relevant learned medical associations for respiratory diseases, along with health authorities around the world, recommend continuing treatment, regardless of the type of device, and consulting a physician.
The Canadian Sleep Society is recommending an individualized decision after discussion with the physician when an alternative device can’t be secured in a timely manner. For the sake of our patients’ and clients’ safety, we recommend they seek medical advice regarding their treatment continuum.